|
|
1310 Chesapeake Terrace
Sunnyvale
CA
94089
United States
408-716-4600
|
|
PUBLIC
|
Accuray Incorporated (Nasdaq: ARAY) based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 60,000 patients worldwide and currently more than 164 systems have been installed in leading hospitals in the Americas, Europe and Asia.
Accuray's history began when John R. Adler, M.D., professor of neurosurgery and radiation oncology at Stanford University Medical Center, developed the CyberKnife® System in 1987 after completing a fellowship in Sweden with Lars Leksell, M.D., the founder of radiosurgery. With the CyberKnife System, Adler’s vision was to develop a non-invasive robotic radiosurgery system with superior accuracy for treatment of tumors anywhere in the body. The revolutionary concept reached far beyond the practice of radiosurgery at the time, which restricted radiosurgery to the treatment of intracranial tumors.
After his initial work developing the CyberKnife System, Adler together with a group from Stanford and a manufacturer of linac technology teamed up and founded Accuray Incorporated in 1990. Cleared by the FDA for the treatment of head, neck and upper spine tumors in 1999, the CyberKnife System was the first and only commercially available radiosurgery system to combine image guidance and computer controlled robotics giving birth to the next generation in intelligent robotic radiosurgery.
In 2001, Accuray received FDA clearance to introduce enhancements to the CyberKnife System for the treatment of tumors anywhere in the body. Unlike traditional radiosurgery systems that can only treat tumors in the head and neck, the CyberKnife System was cleared to treat both intracranial and extracranial tumors. And because of its extreme precision, the CyberKnife System does not require invasive head or body frames to stabilize the patient’s movements.
|
|
http://www.accuray.com
|
|
|
|
|
|
|
|
|
|
CyberKnife® Robotic Radiosurgery System Product Literature
The CyberKnife® Robotic Radiosurgery System is the world’s first and only radiosurgery system designed to treat tumors anywhere in the body with sub-millimeter accuracy. Using image guidance technology and computer controlled robotics, the CyberKnife System is designed to continuously track the tumor, detect its location and correct for tumor and patient movement in real-time throughout the treatment. Because of its extreme precision, the CyberKnife System does not require invasive head or body
read more...
|
|
|
|
|
|
|